Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Frostman who wrote (18086)	1/24/1999 1:24:00 PM
From: VLAD	Respond to of 23519

Frost, Good work. FWIW, now we can officially say that MUSE is going to be marketed by the THIRD LARGEST PHARMACEUTICAL COMPANY IN THE WORLD. This will include the entire European market, South America, Australia and New Zealand. Let's hope that it will soon include the United States and Japan which would mean that MUSE is going to be marketed in the world's three largest pharmaceutical markets by the third largest pharmaceutical company in the world. Not too shabby when you think about it. It's not a matter of if but when Vivus stock will reach a fair valuation. (IMO currently somewhere between 10 and 15).